Evidence map›Paper›PMID 26397748›Full record

ArticleJournal of chromatography. B, Analytical technologies in the biomedical and life sciences2015

Simultaneous determinations of 17 marker compounds in Xiao-Chai-Hu-Tang by LC-MS/MS: Application to its pharmacokinetic studies in mice.

Rongjin Sun, Min Zeng, Ting Du, Li Li, Guangyi Yang, Ming Hu, Song Gao

Abstract readEvaluation Study
In one paragraph

Article in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Anticancer 20(R)-dammarane-3β,12β,20,25-tetrol-loaded polymeric micelles: Preparation, quantification and pharmacokinetics.Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2016
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Rongjin SunCollege of Pharmacy, Hubei University of Medicine, 30 South Renmin Road, Shiyan, Hubei, China; Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, The University of Houston, 1441 Moursund Street, Houston, TX 77030, USA.
Min ZengDepartment of Pharmacy, Taihe Hospital, Hubei University of Medicine, 32 South Renmin Road, Shiyan, Hubei, China.
Ting DuDepartment of Pharmacy, Taihe Hospital, Hubei University of Medicine, 32 South Renmin Road, Shiyan, Hubei, China.
Li LiCollege of Pharmacy, Hubei University of Medicine, 30 South Renmin Road, Shiyan, Hubei, China; Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, The University of Houston, 1441 Moursund Street, Houston, TX 77030, USA.
Guangyi YangDepartment of Pharmacy, Taihe Hospital, Hubei University of Medicine, 32 South Renmin Road, Shiyan, Hubei, China.
Ming HuCollege of Pharmacy, Hubei University of Medicine, 30 South Renmin Road, Shiyan, Hubei, China; Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, The University of Houston, 1441 Moursund Street, Houston, TX 77030, USA.
Song GaoCollege of Pharmacy, Hubei University of Medicine, 30 South Renmin Road, Shiyan, Hubei, China; Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, The University of Houston, 1441 Moursund Street, Houston, TX 77030, USA. Electronic address: sgao3@uh.edu.
Hubei University of Medicine · CN

Funding

Disposition of Flavonoids via Metabolic InterplayR01GM070737 · NIGMS · UNIVERSITY OF HOUSTON · PI HU, MING · 2006 to 2017
$3.7M
NIGMS NIH HHS GM070737NIGMS NIH HHS R01 GM070737
6 · The paper itself

Abstract

The purpose of this study is to develop and validate an UPLC-MS/MS method to quantify different marker compounds from Xiao-Chai-Hu-Tang (XCHT, a Chinese traditional herbal) in biological samples and apply the method to pharmacokinetic study. A Waters BEH C18 UPLC column was used with acetonitrile/0.1% formic acid mobile phases. The mass analysis was performed in a triple quadrupole mass spectrometer using multiple reaction monitoring (MRM) with positive scan mode. A one-step protein precipitation by methanol was used to extract the analytes from blood. Seventeen commercially available compounds from the different compositing herbals were selected as markers. The results revealed that all of the calibration curves showed good linear regression (r(2)>0.9918). The intra-day and inter-day precisions (RSD) of all of these markers at three different levels were less than 15.0% and the bias of the accuracies ranged from -13.5% to 16.6%.The extraction recoveries of all of these 17 markers were from 70.8% to 113.7% and the matrix effects ranged from 71.8% to 114.8%. The stabilities of these compounds in blood were evaluated by analyzing three replicates of QC samples at three different concentrations following storage at 25°C for 6h, 4°C for 24h, and -80°C for 30 days. All the samples displayed 85-115% precision and accuracy after various stability tests. The validated method was successfully applied to pharmacokinetic study in A/J mouse with oral administration of XCHT. All of these markers were detected and the pharmacokinetic parameters of 8 compounds were able to be calculated. This method is sensitive and reproducible that can be used for XCHT's in vivo study.

Indexed as

AnimalsBlood Chemical AnalysisChromatography, High Pressure LiquidDrugs, Chinese HerbalMaleMiceSensitivity and SpecificityTandem Mass SpectrometryDrugs, Chinese HerbalPharmacokineticsUPLC–MS/MSXiao–Chai–Hu–Tang

Identifiers

PMID26397748
PMCPMC4608253
OpenAlexW1663211069

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.